Certains éléments peuvent ne pas apparaître en raison des règles de confidentialité.
Veuillez mettre à jour vos critères de recherche et essayer à nouveau
During this session, the members of the Partnership of Immunization Networks (PIN) will introduce their respective platforms and show how they can help immunization professionals in their job. Some time will also be allocated for questions and answers.
The Partnership of Immunization Networks (PIN) is composed of:
BOOST https://boostcommunity.org/
The Geneva Learning Foundation https://www.learning.foundation/
Immunization Academy https://watch.immunizationacademy.com/
IAPHL https://iaphl.org/
TechNet-21 www.technet-21.org
REGISTRATION: https://who.zoom.us/meeting/register/tJYldeutrjosEtxl1XHL3q2PGmzFoy4klUcd
TechNet-21 is a member of the Partnership of Immunization Networks (PIN), which has been created to strengthen collaboration between organizations that serve distinct yet interconnected online communities of immunization professionals. The PIN provides a convening mechanism for member organizations to better meet the needs of their respective communities, with the goal of enabling immunization professionals to strengthen immunization services – and thereby vaccination coverage rates – around the world. In this closing plenary session of Day one, we will hear from the different members of the PIN and learn about the services they provide.
The Partnership of Immunization Networks
Dan Brigden
TechNet-21
Alex Pascutto (WHO)
BOOST
Sarah Kester
The Geneva Learning Foundation
Reda Saki
IAPHL
Walter Proper
Immunization Academy
Nathan Pienkowski
Introducing the PIN Marketplace
Dan Brigden (WHO)
Registration: https://who.zoom.us/meeting/register/tJYldeutrjosEtxl1XHL3q2PGmzFoy4klUcd
The opening ceremony of the 16th TechNet Conference.
Conference opening
Soulemane Kone (WHO).
Opening remarks
Ann Lindstrand (WHO)
Robin Nandy (UNICEF)
Alex de Jonquieres (Gavi)
Building resilience in the ‘global South’: A message from Senegal
Dr Marie Khémesse Ngom Ndiaye (Director-General, Ministry of Health, Senegal).
Ensuring that countries are ready for a Covid-19 vaccine
Benjamin Schreiber (UNICEF)
Overview of the Country Readiness and Delivery (CRaD) working group that is co-lead by WHO and UNICEF and is developing tools, guidance and approaches to ensure countries are ready for a covid-19 vaccine introduction. The objective is to coordinate approaches with key stakeholders and partners, communicate and monitor progress.
Ensuring access to medication: innovating to minimize the impact of COVID-19: A message from the winner of the Oman Youth Covid-19 Innovation Challenge
Saada Al Salti (Team Teryaq)
The global pandemic has been a rallying call for youth innovators and entrepreneurs across the world. Young people are eager to contribute their talents and passion to helping those in need, and making societies more resilient. Saada Al Salti is team lead of Team Teryaq – the winners of the Oman Youth Covid-19 Innovation Challenge. It was held in June with support from the Oman Technology Fund and Unicef, to engage young local innovators and startups with the goal of creating solutions for health and education sectors that are rooted in technology.
This session will investigate the ways in which national immunization programs can reach particular Covid-19 vaccine target groups, such as healthcare workers and the elderly. While most of the countries have conducted multiple mass vaccination campaign for infants and adolescents, many other may not have yet developed adequate experience vaccinating the elderly. We have conveyed a panel of global and regional supply chain experts from WHO and UNICEF to discuss strategies for adapting existing practices to ensure that the future requirements of immunizing target groups with a new Covid-19 vaccine can be met. We will be presenting perspectives from two regions: Europe and Africa.
Adama Sawadogo (UNICEF PD) will present the strategies under consideration at the global level to reach and vaccinate healthcare workers and the elderly.
Oleg Benes (WHO EURO), will present the existing immunization delivery platforms in Europe for healthcare workers and elderly and how these platforms can be leveraged for the covid-19 vaccination.
Serge Ganivet (UNICEF WCARO) and Claude Mangobo (WHO AFRO) will present the potential strategies and the challenges for reaching and vaccinating these targets groups in the context of the African region.
Presenters:
Souleymane Kone (WHO)
Adama Sawadogo (UNICEF PD)
Serge Ganivet (UNICEF WCARO)
Oleg Benes (WHO EURO)
Claude Mangobo (WHO AFRO)
During the session, we will not only learn about how UPS is currently contributing to making the global, regional and local supply chains capable and ready to deliver future Covid19 vaccines, but also discuss the future of logistics where the regional and local private sector would play a bigger role.
Speakers:
Olivier Defawe (VillageReach)
Maeve Magner (Ind.)
Chris Larson (UPS)
As the impact of COVID-19 continues to disrupt immunisation services, reaching underserved communities and zero dose children has become more critical than ever. In a bid to assist countries with practical solutions to reach these children through necessary adaptations in iSC interventions, this session looks at the ERG-identified challenges in the diverse settings of Remote rural, Urban poor and Conflict areas and then identifies the most likely immunization program operational strategies to overcome these challenges. Each of these operational strategies and adaptations are discussed in terms of the iSC implications, challenges and opportunities. Michelle Seidel from UNICEF HQ introduces the topic and provides some context to the challenges. Her presentation is followed by practical country strategies in Afghanistan, Nigeria and Pakistan jointly presented by MoH and UNICEF.
Moderator: Srihari Dutta (UNICEF ROSA)
Speakers:
Ahmadu Yakubu (UNICEF);
Michelle Seidl (UNICEF);
Ranjit Dhiman (UNICEF);
Eshioramhe Kelobo (UNICEF);
Kibura Daradara (NPHCDA)
COVID-19 pandemic has provided countries with the challenges but also opportunities to innovate for better coordinating national and sub-national immunization supply chains and for mitigating immunization services disruptions. With the forthcoming COVID-19 mass vaccination, the NLWGs will play a critical role in preparing and coordinating one of the biggest logistic operations of the Century: delivering millions of COVID-19 vaccine doses and other ancillary products while maintaining the other essential immunization services. This interactive session will share experiences from selected countries on the role the NLWGs have played in maintaining immunization services amidst COVID-19 challenges and in building immunization supply chain resilience for current future vaccination strategies including country ISC preparedness for COVID-19 vaccine operations.
Moderator: Patrick Gaparayi (UNICEF)
Presenters:
- Hassan Sibomana (Rwanda Biomedical Centre)
- Marius Vouking (Cameroon MoH)
The COVID-19 pandemic has made evident the need to move from internationally-dependent TA towards a continuous and sustainable capacity development approach. The increasing complexities of the supply chains merit more distributed TA models that can be implemented by a network of national institutions, such as, government agencies, academic institutions, vocational training centres, private companies and NGOs. New EVM2 functionalities enable its use as a continuous capacity development delivery mechanism addressing equity gaps of the ISCM workforce at subnational level, thus making EVM2 a tool for measurement of TA delivery effectiveness.
Moderator: Dmitri Davydov (UNICEF Programme Division)
Presenters:
- Arletty Pinel (advisor, global health and systems strengthening)
- Graça Masinhe (Director, Mozambique EPI)
- Moussa Yazi (Head, Business Development Unit, CESAG)
The demand for cold chain storage has increased as more temperature-sensitive health products become available for primary health care service delivery. What could be the practical solution to safely manage the storage and transport of these products without causing too much burden on the cold chain? Learn from countries achieving supply chain efficiency through an integrated approach.
Moderator: Maricel Castro (WHO)
Overview of the WHO-UNICEF Joint statement
Michelle Seidel (PD, UNICEF HQ)
Specific guidance for an effective integration
Maricel Castro (EPI, WHO HQ)
Integration of Immunization Supply Chain in to the Wider Health Supply Chain
Tariku Berhanu (UNICEF CO Ethiopia)
Integration of EPI supply chain including CCE Inventory in the DHIS-2 platform
Monjurul Islam Fuad (MOH Bangladesh)
Question and answer
Moderated by Dereje Haile (UNICEF ESARO)
During this session, we will hear how the Government of Liberia with technical assistance from the VillageReach team developed a dashboard to visualize PPE Stock in order to inform decision makers. We will hear lots of lessons learned about trying to get visibility and data use during a crisis.
Presenter(s):
Arthur Loryoun (VillageReach)
Data management systems are key for providing logistic data end to end visibility but only if they “talk” to each other. During this session, we will explore how the Government of Malawi is using Chipatala cha pa Foni Hotline Data to Inform COVID-19 related Decision-Making.
Presenters:
Upile Kachila (VillageReach)
Bwighane Mwalwanda (Luke International).
End visibility of logistic data is a key factor for ensuring products availability to our communities. During this session, we will look at the latest OpenLMIS CoVID edition as a rapid adaptation of a global good to support supply chains during COVID.
Presenter: Wes Brown (OpenLMIS community)
How much more are we willing to pay for a vaccine that can be used outside of the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good investment for national immunization programs? This presentation will address these questions, presenting the key economic arguments in favour of CTC implementation from a country perspective.
Presenters: Anna-Lea Kahn (WHO); Mercy Mvundura (PATH)
Registration: https://who.zoom.us/meeting/register/tJYldeutrjosEtxl1XHL3q2PGmzFoy4klUcd
Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of immunized children. Consequently, there were over 140,000 deaths globally, in 2018. Novel and improved vaccine delivery platforms such as microarray patches (MAPs) are needed to address the increasing challenge of achieving and sustaining effective vaccination of MRVs, to achieve the eradication of measles and rubella, a goal set by the WHO and partners. MAPs offer competitive advantages over needle and syringe (NS) vaccine delivery. They have a potential to be more thermostable and freeze resistant, do not require reconstitution resulting in an improved safety profile, they are easier to use, do not contain sharps, and are more acceptable by caregivers and vaccinees.
Measles and rubella MAPs (MR-MAPs) will soon enter phase one clinical trials and although early in development, critical actions are needed to prepare the pathway for late stage product development and mitigate against delays in scale up. The lack of a clear demand forecast for MR-MAP has been identified as significant bottleneck in the investment of this urgently needed innovative vaccine. In order to address this, the WHO is working with public health stakeholders at the country level to assess how MR-MAPs will be used, the critical product attributes that are required for use to achieve impact, and the potential demand for such products.
Presenter: Mateusz Hasso-Agopsowicz (WHO)
Registration link: https://who.zoom.us/meeting/register/tJYldeutrjosEtxl1XHL3q2PGmzFoy4klUcd
The Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH – known as the VIPS Alliance - to develop a single integrated framework to evaluate and prioritise innovations in vaccine product delivery that meet country needs. The goal of VIPS is to provide greater clarity to manufacturers and partners to inform and influence investment decisions, and to drive these innovations forward. This presentation will discuss the prioritisation process, the 3 prioritised innovations / approaches and the proposed next steps to advance them.
Presenters: Gitte Giersing (WHO), Marion Menozzi-Arnaud (Gavi)
The 16th TechNet Conference will take place on Tuesday, October 20 and Wednesday, October 21.
Sessions will be organised into four key themes, identified by TechNet members as critically important, with two per day.
Day one (Tuesday)
- Supply chain strategies
- Effective vaccine management
Day two (Wednesday)
- Responding to Covid-19
- Cold chain equipment
The overall program will be the same on both days:
- Short sessions will take place from 09:00-12:00 CET
- Plenary and breakout sessions will take place from 15:00-18:30 CET.
- The Marketplace will take place from 18:30-19:30 CET on both days
- The short sessions from the morning will be repeated later on the same day from 19:30-22:30 CET
Agenda at-a-glance: www.technet-21.org/library/main/6599
Full agenda: www.technet-21.org/conference/2020/agenda
Registration: https://who.zoom.us/meeting/register/tJYldeutrjosEtxl1XHL3q2PGmzFoy4klUcd